Logo image of DSFIR.AS

DSM-FIRMENICH AG (DSFIR.AS) Stock Price, Quote, News and Overview

AMS:DSFIR - Euronext Amsterdam - CH1216478797 - Common Stock - Currency: EUR

96  -0.72 (-0.74%)

DSFIR.AS Quote, Performance and Key Statistics

DSM-FIRMENICH AG

AMS:DSFIR (3/7/2025, 7:00:00 PM)

96

-0.72 (-0.74%)

Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals
Statistics
52 Week High124.85
52 Week Low93.32
Market Cap25.51B
Shares265.68M
Float263.72M
Yearly DividendN/A
Dividend Yield2.58%
PE10.51
Fwd PE29.55
Earnings (Next)04-30 2025-04-30
IPO04-18 2023-04-18


DSFIR.AS short term performance overview.The bars show the price performance of DSFIR.AS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

DSFIR.AS long term performance overview.The bars show the price performance of DSFIR.AS in the last 1, 2 and 3 years. 1 year 2 years 3 years -2 -4 -6

The current stock price of DSFIR.AS is 96 EUR. In the past month the price increased by 0.59%. In the past year, price decreased by -6.6%.

DSM-FIRMENICH AG / DSFIR Daily stock chart

DSFIR.AS Competitors/Peers

The largest stocks on the EU markets in the "Specialty Chemicals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
6D81.DE DUPONT DE NEMOURS INC 19.09 29.92B
BRG.OL BORREGAARD ASA 21.84 18.00B
ELK.OL ELKEM ASA 29.74 14.84B
SY1.DE SYMRISE AG 34.09 13.39B
1COV.DE COVESTRO AG N/A 11.08B
AKZA.AS AKZO NOBEL N.V. 15.78 10.49B
EVK.DE EVONIK INDUSTRIES AG 27.39 10.08B
AMC.DE ALBEMARLE CORP N/A 8.33B
SYENS.BR SYENSQO SA N/A 7.47B
AKE.PA ARKEMA 10.06 6.30B
WCH.DE WACKER CHEMIE AG 30.92 4.02B
NVJP.DE UMICORE N/A 2.19B

About DSFIR.AS

Company Profile

DSFIR logo image DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.

Company Info

DSM-FIRMENICH AG

Wurmisweg 576, Kaiseraugst

Kaiseraugst AARGAU CH

Employees: 27926

Company Website: https://www.dsm-firmenich.com/corporate/home.html

Investor Relations: http://www.dsm-firmenich.com/corporate/investors/

DSM-FIRMENICH AG / DSFIR.AS FAQ

What is the stock price of DSM-FIRMENICH AG today?

The current stock price of DSFIR.AS is 96 EUR. The price decreased by -0.74% in the last trading session.


What is the ticker symbol for DSM-FIRMENICH AG stock?

The exchange symbol of DSM-FIRMENICH AG is DSFIR and it is listed on the Euronext Amsterdam exchange.


On which exchange is DSFIR.AS stock listed?

DSFIR.AS stock is listed on the Euronext Amsterdam exchange.


What is the price forecast or stock price prediction for DSM-FIRMENICH AG stock?

31 analysts have analysed DSFIR.AS and the average price target is 133.09 EUR. This implies a price increase of 38.64% is expected in the next year compared to the current price of 96. Check the DSM-FIRMENICH AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is DSM-FIRMENICH AG worth?

DSM-FIRMENICH AG (DSFIR.AS) has a market capitalization of 25.51B EUR. This makes DSFIR.AS a Large Cap stock.


How many employees does DSM-FIRMENICH AG have?

DSM-FIRMENICH AG (DSFIR.AS) currently has 27926 employees.


What are the support and resistance levels for DSM-FIRMENICH AG (DSFIR.AS) stock?

DSM-FIRMENICH AG (DSFIR.AS) has a support level at 95.12 and a resistance level at 100.77. Check the full technical report for a detailed analysis of DSFIR.AS support and resistance levels.


Is DSM-FIRMENICH AG (DSFIR.AS) expected to grow?

The Revenue of DSM-FIRMENICH AG (DSFIR.AS) is expected to grow by 9.37% in the next year. Check the estimates tab for more information on the DSFIR.AS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy DSM-FIRMENICH AG (DSFIR.AS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does DSM-FIRMENICH AG (DSFIR.AS) stock pay dividends?

DSM-FIRMENICH AG (DSFIR.AS) has a dividend yield of 2.58%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of DSFIR.AS dividend history, reliability and sustainability.


When does DSM-FIRMENICH AG (DSFIR.AS) report earnings?

DSM-FIRMENICH AG (DSFIR.AS) will report earnings on 2025-04-30.


What is the Price/Earnings (PE) ratio of DSM-FIRMENICH AG (DSFIR.AS)?

The PE ratio for DSM-FIRMENICH AG (DSFIR.AS) is 10.51. This is based on the reported non-GAAP earnings per share of 9.13 and the current share price of 96 EUR. Check the full fundamental report for a full analysis of the valuation metrics for DSFIR.AS.


DSFIR.AS Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to DSFIR.AS. When comparing the yearly performance of all stocks, DSFIR.AS is a bad performer in the overall market: 83.96% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

DSFIR.AS Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to DSFIR.AS. DSFIR.AS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DSFIR.AS Financial Highlights

Over the last trailing twelve months DSFIR.AS reported a non-GAAP Earnings per Share(EPS) of 9.13.


Industry RankSector Rank
PM (TTM) 20.05%
ROA 6.22%
ROE 9.3%
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

DSFIR.AS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to DSFIR.AS. The Buy consensus is the average rating of analysts ratings from 31 analysts.

For the next year, analysts expect an EPS growth of 65.75% and a revenue growth 9.37% for DSFIR.AS


Ownership
Inst Owners32.04%
Ins Owners27.75%
Short Float %N/A
Short RatioN/A
Analysts
Analysts81.94
Price Target133.09 (38.64%)
EPS Next Y65.75%
Revenue Next Year9.37%